Stromagen

Stromagen is a product that is made of stem cells taken from a patient's bone marrow and grown in the laboratory. After a patient's bone marrow is destroyed by treatment with whole body irradiation or chemotherapy, these cells are injected back into the patient to help rebuild bone marrow. Stromagen has been studied in the prevention of graft-versus-host disease during stem cell transplant in patients receiving treatment for cancer. Stromagen is used in cellular therapy. Also called autologous expanded mesenchymal stem cells OTI-010.^[1]^[2] Peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy and kill more tumor cells. It is not yet known whether Stromagen improves the success of stem cell transplantation in women with breast cancer.^[3]

References

^ "NCI Dictionary of Cancer Terms". National Cancer Institute. This article incorporates text from this source, which is in the public domain.
^ "Glossary - Maryland Oncology". marylandoncology.com.^{[permanent dead link]}
^ "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. May 11, 2017. Retrieved May 11, 2017. This article incorporates text from this source, which is in the public domain.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

[1] "NCI Dictionary of Cancer Terms". National Cancer Institute. This article incorporates text from this source, which is in the public domain.

[2] "Glossary - Maryland Oncology". marylandoncology.com.^{[permanent dead link]}

[3] "Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. May 11, 2017. Retrieved May 11, 2017. This article incorporates text from this source, which is in the public domain.

[1]

[2]

[3]